Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome

Supporting evidence

• Review decision

• Review decision – May 2018

• Review decision paper (PDF 370 KB)

  Published:

  17 May 2018

• Matrix of stakeholders (PDF 275 KB)

  Published:

  17 May 2018